Cost–benefit evaluation of influenza vaccination in the elderly in the Italian region of Liguria
Authors:
- R GaspariniRGR Gasparini
- C LucioniCLC Lucioni
- P LaiPLP Lai
- P MaggioniPMP Maggioni
- L SticchiLSL Sticchi
- P DurandoPDP Durando
- P MorelliPMP Morelli
- I CominoICI Comino
- S CalderisiSCS Calderisi
- P CrovariPCP Crovari
Abstract
No abstract availableKeywords
Funding Information
- Ministero dell’Istruzione, dell’Università e della Ricerca
This publication has 8 references indexed in Scilit:
- Individual and Community Impact of InfluenzaPharmacoEconomics, 1999
- The Health and Economic Benefits of Influenza Vaccination for Healthy and At-Risk Persons Aged 65 to 74 YearsPharmacoEconomics, 1999
- Benefits of Influenza Vaccination for Low-, Intermediate-, and High-Risk Senior CitizensArchives of internal medicine (1960), 1998
- Economic Evaluation of Influenza Vaccination and Economic ModellingPharmacoEconomics, 1996
- Health Impact of Influenza in the United StatesPharmacoEconomics, 1996
- The Efficacy of Influenza Vaccine in Elderly PersonsAnnals of Internal Medicine, 1995
- Immunization Policies and Vaccine Coverage Among AdultsAnnals of Internal Medicine, 1988
- Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970-78.American Journal of Public Health, 1986